Literature DB >> 3014942

Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Centers for Disease Control, U.S. Department of Health and Human Services.

.   

Abstract

Infection with the human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) [now human immunodeficiency virus] can manifest as a spectrum of conditions ranging from severe immunodeficiency to asymptomatic infection. Because of the rapid growth of knowledge about this virus, there is a need for a system to classify patients with the various manifestations of infection. The presented system comprises four mutually exclusive groups: I, acute infection; II, asymptomatic infection, III, persistent generalized lymphadenopathy; and IV, other HTLV-III/LAV disease (with five subgroups, A to E, and two subcategories, C-1 and C-2). The classification should be useful in disease reporting and surveillance, epidemiologic studies, prevention and control activities, and public health policy and planning.

Entities:  

Mesh:

Year:  1986        PMID: 3014942

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  21 in total

1.  Acquired immune deficiency syndrome (AIDS) and autoimmunity--mutually exclusive entities?

Authors:  A M Solinger; L E Adams; A E Friedman-Kien; E V Hess
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

2.  Prevalence of HIV infection in 646 heroin addicts and outcome of HIV-related conditions in the 266 followed up.

Authors:  C Mandelli; D Conte; R Barbera; T Masullo; S Pistoso; G P Aimo; L Cesarini; M Fraguelli; G P Lorini; P A Bianchi
Journal:  Eur J Epidemiol       Date:  1991-01       Impact factor: 8.082

3.  The management of anorectal disease in HIV-positive patients.

Authors:  L G Gottesman; A J Miles; J W Milsom; J M Northover; W P Schecter; A Stotter
Journal:  Int J Colorectal Dis       Date:  1990-05       Impact factor: 2.571

4.  Urinary neopterin: an early marker of HIV infection.

Authors:  H Kofler; D Fuchs; H Hintner; H Wachter; P Fritsch
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267

5.  AIDS-related cholangiopathy. Critical analysis of a prospective series of 26 patients.

Authors:  Y Benhamou; E Caumes; Y Gerosa; J F Cadranel; E Dohin; C Katlama; P Amouyal; J M Canard; N Azar; C Hoang
Journal:  Dig Dis Sci       Date:  1993-06       Impact factor: 3.199

6.  High-dose intravenous immunoglobulins in the treatment of adolescent and adult HIV-infected hemophiliacs.

Authors:  U Wintergerst; K Niinivaara-Kreuzer; G Notheis; K Auberger; C Brückmann; S Gandenberger; B H Belohradsky
Journal:  Clin Investig       Date:  1994-01

7.  Human immunodeficiency virus (HIV)-related chronic relapsing inflammatory demyelinating polyneuropathy with multifocal unusual onion bulbs in sural nerve biopsy. A clinicomorphological study with qualitative and quantitative light and electron microscopy.

Authors:  E Gibbels; N Diederich
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

8.  A simple clinical staging system that predicts progression to AIDS using CD4 count, oral thrush, and night sweats.

Authors:  L Rabeneck; M M Crane; J M Risser; C E Lacke; N P Wray
Journal:  J Gen Intern Med       Date:  1993-01       Impact factor: 5.128

9.  Impaired in vitro growth of peripheral blood hematopoietic progenitor cells in HIV-infected patients: evidence of an inhibitory effect of autologous T lymphocytes.

Authors:  E Balleari; S Timitilli; F Puppo; L Gaffuri; C Musselli; F Rizzo; F Indiveri; R Ghio
Journal:  Ann Hematol       Date:  1991-12       Impact factor: 3.673

10.  Association of lipid accumulation in small intestinal mucosa with decreased serum triglyceride and cholesterol levels in AIDS.

Authors:  Y Benhamou; I Hilmarsdottir; I Desportes-Livage; C Hoang; A Datry; M Danis; M Gentilini; P Opolon
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.